SFU
AVNR

Stonehage Fleming (UK)’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Stonehage Fleming (UK)’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-1,167
Closed -$14K – 364
2014
Q3 		$14K Buy
+1,167
New +$7.97K 0.01% 279
2014
Q1 		– Sell
-8,876
Closed -$30K – 346
2013
Q4 		$30K Buy
+8,876
New +$36.7K 0.01% 253

Other funds holding AVNR

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Stonehage Fleming (UK)'s AVNR Position: Q4 2014 in Review

Stonehage Fleming (UK) sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q4 2014, closing a stake of 1,167 shares — an estimated $14K sold.

Stonehage Fleming (UK) first reported a position in AVNR in Q4 2013 and held it in 2 quarters. The position peaked at $30K in Q4 2013. 166 funds tracked by Wall St. Rank hold AVNR as of Q4 2014.

  • Stonehage Fleming (UK) reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q4 2014 after selling out during the quarter.
  • Stonehage Fleming (UK) sold 1,167 AVANIR PHARMACEUTICALS, INC CL A shares in Q4 2014, an estimated $14K.
  • Stonehage Fleming (UK) first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2013 and held it in 2 quarters.
  • Stonehage Fleming (UK)'s AVANIR PHARMACEUTICALS, INC CL A position peaked at $30K in Q4 2013.
  • 166 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q4 2014.

Based on Stonehage Fleming (UK)'s 13F filing for Q4 2014, filed 11 Oct 2019.